Clinical and Translational Research Sector Clinical Phenome Group

Group Introduction

Leader:
Professor Ritsuko Shimizu (Graduate School of Medicine)

This group conducts integrated multi-omics analyses to identify disease-related markers for diagnostics, treatment, and prevention. It also develops data platforms to assess disease susceptibility through metabolome, proteome, and microbiome profiling. By advancing metabolome and proteome analysis of biological samples, this group aims to apply these approaches to cancer type identification, treatment efficacy evaluation, and prognosis prediction. Additionally, the group is expanding the range of measurable metabolites and sample types to include non-cancer diseases. In parallel, ongoing projects focus on collecting metagenomic samples and analyzing temporal changes in the microbiome associated with diseases such as ovarian cancer, oral cancer, and brain tumors.

Organization